To reach those goals, it is necessary to screen and segregate the positives with dedicated pathways for further diagnostic testing and treatment, regardless of the admitting diagnosis. A committed health care team would be ideal: chosen among the immunes (if this coronavirus generates a consistent and persistent immune response) or among those with less risk factors to develop a severe COVID-19. To stress this idea, the foundation of a SARS-CoV-2 Hub Center seems to be an option to eradicate the risk of in-hospital infection in non-COVID-19 patients, who are the most at risk. Regarding pathologies that merit priority for treatment, it is reasonable to focus on those valvular diseases that directly may have an associated degree of pulmonary hypertension (PH).  PH associated with left heart disease (Nice group 2) is by far the most common cause of PH and accounts for 50–85% of the cases. Based on the pathological findings and on the suspected mechanism of lung damage, an increased pressure in the pulmonary artery may further compromise the effective oxygen/carbon dioxide exchange in the alveoli. Rest echocardiography is essential to assess the presence of pulmonary hypertension in the symptomatic patient with left side valvular diseases. Furthermore, in order to correctly identify and stratify asymptomatic patients with a degree of pulmonary hypertension, exercise echocardiography is crucial.  The prevalence of PH almost doubles under effort in patients with mitral regurgitation and increases almost 10 fold in asymptomatic patients with severe aortic stenosis(19).